Last reviewed · How we verify

NCT04202666

The Role of Convex Skin Barrier in Prevention of Peristomy Skin Complication-Randomized Controlled Trial

Status unknown NA Last updated 16 September 2020
What this trial tests

NA trial testing convex skin barrier in Stoma Colostomy in 300 participants. Status unknown.

Timeline
31 August 2020
Primary endpoint
31 October 2021
31 December 2021

Quick facts

Lead sponsorChang Gung Memorial Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposesupportive care
Enrollment300
Start date31 August 2020
Primary completion31 October 2021
Estimated completion31 December 2021
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

20 and older, any sex, with Stoma Colostomy or Stoma Ileostomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The incidence of peristomy skin complication ranges from 15% to 65%. It is a serious issue and problem for patients care.The type of skin barrier is associated with peristomy skin complication. How to choose suitable skin barrier is important.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease.
    Vuyyuru SK, Ma C, Sharma T, Nguyen TM, et al · · 2024 · cited 3× · PMID 38135729 · DOI 10.1093/ibd/izad293

Verify or expand the search:

Other recruiting trials for Stoma Colostomy

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04202666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing